Skip to main content

Phosphocreatine


Basic information
Metabolite name

Phosphocreatine

HMDB0001511
C02305
587
Synonyms

Phosphoctreatine

No. of studies

13

 

Relationship between Phosphocreatine and depression (count: 13)
Study Study Type Comparison groups Tissue Organism Up/Down regulated
Study M116 Type3 ketamine group vs. control group Hippocampus Sprague-Dawley rat Up
Study M116 Type3 ketamine group vs. control group Cerebrospinal fluid Sprague-Dawley rat Up
Study M134 Type1 CRS group vs. control group Urine Sprague-Dawley rat Down
Study M134 Type2 CRS + BH group vs. CRS group Urine Sprague-Dawley rat Up
Study M237 Type3 SAMe-treated post-treatment vs. pre-treatment Brain Human Up
Study M260 Type4 T3 augmentation treatment responder group vs. non-responder group Brain Human Down
Study M286 Type2 creatine-treated depression group post-treatment vs. pre-treatment Brain Human Up
Study M317 Type2 creatine-treated depression group post-treatment vs. pre-treatment group Frontal lobe Human Up
Study M348 Type1 depression group vs. control group Gray matter Human Up
Study M348 Type1 depression group vs. control group White matter Human Down
Study M460 Type1 depressed group vs. control group Liver Kunming mouse Up
Study M461 Type1 LD group vs. control group Prefrontal cortex Sprague-Dawley rat Up
Study M595 Type1 CRS group vs. control group Nucleus accumbens C57BL/6J mouse Down
Study M595 Type2 CRS + acetyl-L-carnitine group vs. CRS group Nucleus accumbens C57BL/6J mouse Up
Study M799 Type1 MDD group vs. control group Middle temporal visual area Human Down
Study M809 Type1 CUMS group vs. control group Serum Kunming mouse Up
Study M809 Type2 CUMS + Milletia speciosa Champ group vs. CUMS group Serum Kunming mouse Down
Study M850 Type1 reserpine group vs. control group Brain C57BL/6 mouse Up